SCHEMBL17756860

SCHEMBL17756860

c1ccc2c(c1)oc1ccc(-c3ccnc(-c4ccc5oc6ccccc6c5c4)n3)cc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.47
▸ MAPT P10636 4/20 0.47
▸ RAB9A P51151 4/20 0.47
▸ KDM4E B2RXH2 4/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ POLB P06746 1/20 0.47
▸ ALDH1A1 P00352 3/20 0.45
▸ HPGD P15428 2/20 0.45
▸ PIM1 P11309 4/20 0.43
▸ PIM3 Q86V86 4/20 0.43
▸ PIM2 Q9P1W9 4/20 0.43
▸ CHEK2 O96017 1/20 0.43
▸ AHR P35869 2/20 0.41
▸ CASP3 P42574 2/20 0.41
▸ SENP7 Q9BQF6 2/20 0.41
▸ SENP6 Q9GZR1 2/20 0.41
▸ LMNA P02545 1/20 0.38
▸ HCRTR1 O43613 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15835949 0.98 NPC1 (0.46) NPC1MAPTRAB9AKDM4ESMN1; SMN2
SCHEMBL15855183 0.94 MAPT (0.46) NPC1MAPTRAB9AKDM4ESMN1; SMN2
SCHEMBL22376607 0.92 MAPT (0.47) NPC1MAPTRAB9AKDM4ESMN1; SMN2
SCHEMBL22376052 0.90 MAPT (0.45) NPC1MAPTRAB9AKDM4ESMN1; SMN2
SCHEMBL15835974 0.89 ROCK1 (0.40) NPC1MAPTRAB9AKDM4ESMN1; SMN2
SCHEMBL22375603 0.87 KDM4E (0.43) NPC1MAPTRAB9AKDM4ESMN1; SMN2
SCHEMBL15855382 0.87 KDM4E (0.44) NPC1MAPTRAB9AKDM4ESMN1; SMN2
SCHEMBL15836062 0.87 NPC1 (0.40) NPC1MAPTRAB9AKDM4ESMN1; SMN2
SCHEMBL15855336 0.86 NPC1 (0.40) NPC1MAPTRAB9AKDM4ESMN1; SMN2
SCHEMBL15855288 0.86 NPC1 (0.40) NPC1MAPTRAB9AKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160141515-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-05-19 — — US disclosed
US-20160141515-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-05-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160141515-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT USING SAME, AND ELECTRONIC DEVICE OR10J3, PIEZO1, L1CAM NPC1 3035/4885MAPT 1447/4885RAB9A 2615/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback